Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Johnson & Johnson COVID-19 Vaccine List of Ingredients

What We Know About PEG, Suspected as the Cause of Reactions to Pfizer’s COVID-19 Vaccine

Moderna COVID-19 Vaccine List of Ingredients

Nanoparticle Appears to Prevent, Treat Peanut Allergies in Mice

Food Allergies Reversed in Mice by Targeting the Microbiome

Sublingual Epinephrine Faster to Maximum Concentration than Auto-Injector, Syringe

Bryn Pharma Completes Study of Nasal Epinephrine vs Auto-Injector for Anaphylaxis

FDA Grants Xolair Breakthrough Therapy Designation for Food Allergies

Intestinal Protein Linked to the Development of Food Allergies

Sublingual Emergency Epinephrine Takes Another Step Forward in Phase 1 Study

Healthcare Worker in Alaska Suffers Anaphylactic Reaction After Pfizer COVID-19 Immunization

Aquestive’s Sublingual Epinephrine Achieves Therapeutic Blood Concentrations Following Administration

FDA Schedules Review of neffy®, an Intranasal Alternative to Epinephrine Auto-Injectors

Study of Boiled Peanuts Show Promise for Treatment of Peanut Allergy

FDA Authorizes Moderna Vaccine, Another Pfizer Vaccine Recipient Has Allergic Reaction

Follow Us

Your School On Our Map

Put Your School on the Map